Dr. Lai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
525 E 68th St
New York, NY 10065Phone+1 212-746-4745
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1988
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Endocrinology, Diabetes, and Metabolism, 1986 - 1987
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1983 - 1986
- Albert Einstein College of MedicineClass of 1983
Certifications & Licensure
- NY State Medical License 1984 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 11 citationsA randomized clinical trial evaluating the efficacy and safety of the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in patients with type 2 diabetes inadeq...R. Ravi Shankar, Silvio E. Inzucchi, Victoria Scarabello, Ira Gantz, Keith D. Kaufman
Current Medical Research and Opinion. 2017-06-23 - 13 citationsA randomized, double-blind, non-inferiority trial evaluating the efficacy and safety of omarigliptin, a once-weekly DPP-4 inhibitor, or glimepiride in patients with ty...Yehuda Handelsman, Brett Lauring, Ira Gantz, Carol Iredale, Edward A. O'Neill
Current Medical Research and Opinion. 2017-06-28 - 20 citationsOrally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor.Douglas G Johns, Louis-Charles Campeau, Puja Banka, An Bautmans, Tjerk Bueters
Circulation. 2023-07-11
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: